SBH
MEDP icon

Segall Bryant & Hamill’s Medpace MEDP Stock Holding History

Segall Bryant & Hamill’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,728
Closed -$7.13M – 617
2025
Q2 		$7.13M Sell
22,728
-19,641
-46% -$5.9M 0.1% 274
2025
Q1 		$12.9M Buy
42,369
+16,872
+66% +$5.68M 0.2% 158
2024
Q4 		$8.47M Sell
25,497
-4,527
-15% -$1.54M 0.12% 255
2024
Q3 		$10M Sell
30,024
-30,888
-51% -$11.7M 0.14% 232
2024
Q2 		$25.1M Buy
60,912
+5,222
+9% +$2.07M 0.44% 70
2024
Q1 		$22.5M Sell
55,690
-11,365
-17% -$4M 0.42% 81
2023
Q4 		$20.6M Buy
67,055
+14,126
+27% +$3.81M 0.4% 83
2023
Q3 		$12.8M Buy
52,929
+406
+0.8% +$104K 0.15% 184
2023
Q2 		$12.6M Buy
52,523
+158
+0.3% +$32.8K 0.13% 199
2023
Q1 		$9.85M Buy
52,365
+317
+0.6% +$65.6K 0.11% 233
2022
Q4 		$11.1M Sell
52,048
-15,657
-23% -$3.13M 0.12% 205
2022
Q3 		$10.6M Sell
67,705
-7,917
-10% -$1.26M 0.13% 197
2022
Q2 		$11.3M Buy
75,622
+9,733
+15% +$1.41M 0.13% 181
2022
Q1 		$10.8M Buy
65,889
+45,912
+230% +$7.57M 0.1% 207
2021
Q4 		$4.35M Sell
19,977
-3,586
-15% -$751K 0.04% 336
2021
Q3 		$4.46M Sell
23,563
-241
-1% -$44K 0.04% 353
2021
Q2 		$4.21M Sell
23,804
-663
-3% -$114K 0.04% 359
2021
Q1 		$4.02M Buy
+24,467
New +$3.74M 0.04% 377

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Segall Bryant & Hamill's MEDP Position: Q3 2025 in Review

Segall Bryant & Hamill sold out of Medpace (MEDP) in Q3 2025, closing a stake of 22,728 shares — an estimated $7.13M sold.

Segall Bryant & Hamill first reported a position in MEDP in Q1 2021 and held it in 18 quarters. The position peaked at $25.1M in Q2 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Segall Bryant & Hamill reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Segall Bryant & Hamill sold 22,728 Medpace shares in Q3 2025, an estimated $7.13M.
  • Segall Bryant & Hamill first reported a position in Medpace in Q1 2021 and held it in 18 quarters.
  • Segall Bryant & Hamill's Medpace position peaked at $25.1M in Q2 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Segall Bryant & Hamill's 13F filing for Q3 2025, filed 12 Nov 2025.